Pediatric drug labeling: Still an unfinished need

Anesthesia and Analgesia

Volumn 115, Issue 5, 2012, Pages 987-988

  Tobin, Joseph R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIRETROVIRUS AGENT; FENTANYL; LIDOCAINE; MIDAZOLAM; MORPHINE; OXYCODONE; PARACETAMOL; RAPACURONIUM BROMIDE;

ANESTHESIA; ANESTHESIST; APOPTOSIS; CHILD; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; DRUG LABELING; EDITORIAL; ELECTRONIC MEDICAL RECORD; HEALTH CARE PERSONNEL; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROTOXICITY; OFF LABEL DRUG USE; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES;

ANALGESICS; ANESTHESIA; ANESTHETICS; DRUG LABELING; FEMALE; HOSPITALIZATION; HUMANS; HYPNOTICS AND SEDATIVES; MALE; OFF-LABEL USE; PEDIATRICS; PHARMACEUTICAL PREPARATIONS;

EID: 84868255389     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31826af996     Document Type: Editorial

References (10)

1. Lasky T, Ernst FR, Greenspan J. Use of analgesic, anesthetic and sedative medications in pediatric hospitalizations in the United States 2008. Anesth Analg 2012;115:1155-61
2. Smith MC, Williamson J, Yaster Y, Boyd GJC, Heitmiller ES. Off-label use of medications in children undergoing sedation and anesthesia. Anesth Analg 2012;115:1148-54
3. Wing DA, Powers B, Hickok D. U.S. Food and Drug Administration drug approval: slow advances in obstetric care in the United States. Obstet Gynecol 2010;115:825-33
4. Fisher JA, Ronald LM. Sex, gender, and pharmaceutical politics: from drug development to marketing. Gend Med 2010;7: 357-70
5. Committee on Drugs. American Academy of Pediatrics. Uses of drugs not described in the package insert (off-label uses). Pediatrics 2002;110:181-3
6. Shaddy RE, Denne SC, Committee on Drugs and Committee on Pediatric Research. Clinical report - guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 2010;125:850-60
7. Giacoia GP, Mattison DR. Newborns and drug studies: the NICHD/FDA newborn drug development initiative. Clin Ther 2005;27:796-813
8. Liu JR, Liu Q, Li J, Baek C, Han XH, Athiraman U, Soriano SG. Noxious stimulation attenuates ketamine-induced neuroapoptosis in the developing rat brain. Anesthesiology 2012; 117:64-71
9. Tobin JR, Shafer SL, Davis PJ. Pediatric research and scholarship: another Gordian knot? Anesth Analg 2006;103:43-8
10. De Oliveira GS Jr, Theilken LS, McCarthy RJ. Shortage of perioperative drugs: implications for anesthesia practice and patient safety. Anesth Analg 2011;113:1429-35